A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion

Clicks: 313
ID: 274115
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #9 of 100 articles by views in molecular therapy : the journal of the american society of gene therapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Adult mammalian brains have largely lost neuroregeneration capability except for a few niches. Previous studies have converted glial cells into neurons, but the total number of neurons generated is limited and the therapeutic potential is unclear. Here, we demonstrate that NeuroD1-mediated in situ a …
Reference Key
yc2020moleculara Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chen YC;Ma NX;Pei ZF;Wu Z;Do-Monte FH;Keefe S;Yellin E;Chen MS;Yin JC;Lee G;Minier-Toribio A;Hu Y;Bai YT;Lee K;Quirk GJ;Chen G;;
Journal molecular therapy : the journal of the american society of gene therapy
Year 2020
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.